
CENTRAL VENOUS CATHETERS
SafeBreak Vascular on Central Venous Catheters (CVC)
SafeBreak Vascular is FDA-cleared for use on hospitals’ most critical lines. In 2023, the FDA expanded its clearance to include PICC lines and central venous catheters.
What are the clinical benefits?
Central lines are critical for delivering life-saving treatments, but even a small displacement of the catheter tip from its intended position can lead to serious complications. This video explains why maintaining the optimal catheter position in the superior vena cava is essential for patient safety. It discusses the risks of catheter migration, blood flow disruption, and thrombosis, which are all issues that can arise from damaging force on an IV line. Watch to learn how SafeBreak Vascular can help protect central lines and support uninterrupted care.
What are the financial benefits?
Central lines are costly and essential for patient care, making their integrity a top priority for patient care providers. The video below breaks down the financial impact of central line dislodgement and how reinsertion costs can range from hundreds to thousands of dollars. It explains the consequences of an accidental CVC removal like delays in treatment, additional procedures, and increased hospital expenses. Watch to understand why placing SafeBreak Vascular on central lines can help improve patient outcomes and reduce hospital costs.
How does SafeBreak Vascular Impact Patient’s Care?
Patient experiences highlight the real impact of SafeBreak Vascular on central lines. This video highlights, the story of a patient who initially questioned the need for SafeBreak but later saw its value firsthand. After experiencing a separation, the patient gained a new appreciation for SafeBreak’s role in protecting their IV access. Watch to hear how SafeBreak aided in the patient’s IV line care and ensured the patient’s treatment stayed on track.
Want to Learn More?
Use the button below to access more information about SafeBreak Vascular on central lines.
Swaminathan, Lakshmi, et al. “Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients with Short-Term Indications.” JAMA Internal Medicine, 29 Nov. 2021, https://doi.org/10.1001/jamainternmed.2021.6844. Accessed 5 Dec. 2021
Fast Facts on U.S. Hospitals, 2024. AHA American Hospital Association. Jan 2024. www.aha.org/statistics/fast-facts-us-hospitals
Adrian, Maria, et al. "Mechanical complications after central venous catheterisation in the ultrasound-guided era: a prospective multicenter cohort study." British journal of anesthesia 129.6 (2022): 843-85.
Data on File
MKG 0339 Rev 00